Drawing for FLASHCAR

USPTO serial 99160199

FLASHCAR

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
Examiner
HWANG, JOHN C B
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).

Status 686: Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance.

Need help with FLASHCAR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Yue Robert Xu

Yue Robert Xu Apex Attorneys at Law, LLP160 Alamo Plaza #942Alamo, CA 94507United States

Goods and services

ClassDescriptionStatusFirst use
005Anti-cancer preparations; Human vaccine preparations; Tumor suppressing agents; Vaccine adjuvants; Cellular function activating agents for medical purposes; Pharmaceutical preparations for the treatment and prevention of cancer and autoimmune diseases; Clinical medical reagents; Biological preparations for the treatment of cancer and autoimmune diseases; Cells for medical or clinical use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical preparations for suppressing tumors; Immunostimulants; Cytostatics for medical purposes; Medical preparations for the treatment of cancer and autoimmune diseases; Biochemical reagents for medical or veterinary purposes; Pharmaceutical preparations containing cultured cells for cancer and autoimmune diseases; Biopharmaceutical preparations for the treatment of cancer and autoimmune diseases; Antibodies for medical purposes; Biological reagents for medical use; Therapeutic pharmaceutical for the treatment of cancer and autoimmune diseasesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 1, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 1, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 26, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 12, 2026OTHECASE RETURNED TO EXAMINATION
Aug 12, 2026IUCNNOTICE OF ALLOWANCE CANCELLED
Aug 12, 2026PCBGPETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Aug 11, 2026APETASSIGNED TO PETITION STAFF
Jun 29, 2026TPADTEAS PETITION TO AMEND BASIS RECEIVED
Jan 13, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 18, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 18, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 12, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 22, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Oct 8, 2025DOCKASSIGNED TO EXAMINER
Oct 6, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 29, 2025MAFRAPPLICATION FILING RECEIPT MAILED
Apr 29, 2025NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance